I was feeling every ounce of my chest cold, the thing everyone apparently has, the one that’s going around, the one that’s not covid but… Read More »Cannabis memory lane: Who’s sticking it out, who’s dead and dying
EQUITY. GURU MARKET NEWS – LIVE FEED Tuesday, April 13th, 2021 [12:17] CLS Holdings (CLSH.C) announces cannabis dispensary revenues up 100% YOY Retail subsidiary, Oasis… Read More »Equity.Guru live market news feed: CLS earnings double, HOPE arranges qualifying transaction, GSY raises $150m
IM Cannabis (IMCC.C) announced its first shipment from its EU-GMP supply partner into Germany yesterday, as well as their three new distribution agreements penned by… Read More »IM Cannabis (IMCC.C) fulfills their medical cannabis distribution duties in Germany
IM Cannabis’ (IMCC.C) subsidiary Focus Medical Herbs signed a supply agreement on July 24 with Ever Green Solomon Pharma to buy all of Ever Green’s… Read More »IM Cannabis (IMCC.C) subsidiary, Focus Medical, buys five-years of medical cannabis for European expansion
Talking to Isracann (IPOT.C) COO Matt Chatterton Monday afternoon I asked a question I ask pretty much everyone in the cannabis world right now: Considering… Read More »The middlemen: Isracann (IPOT.C) and IM Cannabis (IMCC.C) set to capitalize on global weed need
IM Cannabis (IMCC.C) German subsidiary, Adjupharm GmbH, has received three medical cannabis purchase agreements for the next year from the axicorp Group, canymed GmbH, and… Read More »IM Cannabis (IMCC.C) kickstarts their European distribution with three purchase agreements
